ReviewCNS neuroscience & therapeutics2025
Roles and Impacts of Integrative Medical Interventions in Central Nervous System Tumor Treatment: Multi-Technology Convergence and the Paradigm Shift Toward Functional Reconstruction.
Review in CNS neuroscience & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Heterogeneity, Measurement, and Clinical Implications of Oxygenation, Cell Signaling, and Redox Biology in Glioblastoma and Adult Diffuse Gliomas, with Context from Other Brain Tumors.Antioxidants (Basel, Switzerland) · 2026Review
- Roles and Impacts of Integrative Medical Interventions in Central Nervous System Tumor Treatment: Multi-Technology Convergence and the Paradigm Shift Toward Functional Reconstruction.CNS neuroscience & therapeutics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsCentral nervous system (CNS) tumors, particularly glioblastoma, remain a formidable clinical challenge due to their aggressive nature, high heterogeneity, and the restrictive blood-brain barrier. This review aimed to synthesize the roles and impacts of integrative medical interventions in CNS tumor management, highlighting the evolution from traditional monotherapy to multi-technology convergence. It further seeks to address technical barriers and ethical considerations to guide future research and clinical innovation in this field.
methodsThe review discusses a range of integrative medical interventions, including noninvasive neuromodulation, electrotherapy, phototherapy, ultrasound, and magnetotherapy, alongside psychological, nutritional, and herbal medicine approaches. It also evaluates advanced technologies reshaping precision oncology, such as AI-driven diagnostics, 3D organoid models, and multi-omics sequencing, while examining barriers to technical integration and ethical governance issues.
resultsIntegrative medical interventions, combined with multi-technology convergence, play significant roles in CNS tumor management: noninvasive neuromodulation, electrotherapy, phototherapy, ultrasound, and magnetotherapy, together with psychological, nutritional, and herbal approaches, contribute to comprehensive care. Advanced technologies-including AI-driven diagnostics, 3D organoid models, and multi-omics sequencing-enable dynamic disease monitoring, targeted drug delivery, and immune microenvironment remodeling, thereby advancing precision oncology. However, technical integration is hindered by data heterogeneity and translational inefficiency, necessitating standardized frameworks and interdisciplinary collaboration. Additionally, ethical governance is critical for ensuring equitable care.
conclusionThe future landscape of integrative CNS tumor management lies in achieving functional reconstruction through technology-driven innovation, patient-centered care, and global cooperation, with standardized frameworks and interdisciplinary collaboration essential to overcoming existing challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.